BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/14/2021 5:19:47 AM | Browse: 329 | Download: 684
 |
Received |
|
2021-03-24 12:41 |
|
Peer-Review Started |
|
2021-03-24 12:42 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-06-16 14:22 |
|
Revised |
|
2021-06-17 15:18 |
|
Second Decision |
|
2021-08-18 03:16 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-08-18 06:56 |
|
Articles in Press |
|
2021-08-18 06:56 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-08-27 01:05 |
|
Typeset the Manuscript |
|
2021-10-12 06:04 |
|
Publish the Manuscript Online |
|
2021-10-14 05:19 |
| ISSN |
2218-5836 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Orthopedics |
| Manuscript Type |
Case Control Study |
| Article Title |
SARS-CoV-2 outbreak impact on a trauma unit
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Sarah Mills, Aitor Ibarzábal-Gil, José M Martínez-Diez, Javier Pallarés-Sanmartín, Carlos Kalbakdij-Sánchez, Juan C Rubio-Suárez, Itsaso Losantos-García and E Carlos Rodríguez-Merchán |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
E Carlos Rodríguez-Merchán, MD, PhD, Doctor, Doctor, Department of Orthopedic Surgery, La Paz University Hospital, Paseo de la Castellana, 261, Madrid 28046, Spain. ecrmerchan@hotmail.com |
| Key Words |
Trauma department; COVID-19 pandemic; SARS-CoV-2 outbreak; Hip fractures; Morbimortality; Polytraumatic patients |
| Core Tip |
Coronavirus severe acute respiratory syndrome-2 (SARS-CoV-2) infection was not a criterion for choosing conservative treatment, unless those patients infected with the virus had a poor general condition that made surgery unadvisable. We did not find a relationship between the employment of anticoagulant therapy and the severity of coronavirus disease 2019 (COVID-19) infection or a different mortality rate. Patients who died during hospitalization due to COVID-19 had higher C-reactive protein levels (P < 0.001) and higher urea levels (P = 0.006). The mortality rate in 2020 was 13.7% during hospitalization; 19% during the first month after discharge and 24.6% in the three months after discharge. The mortality rate in the COVID-19 positive patients subgroup was 38.9% after 6 mo of follow-up. Non-operative treatment in hip fractures was related to SARS-CoV-2 infection (P = 0.03) and with AO 31.B fractures. Polytrauma patients and high energy fractures were more common in 2019 (24%) than in 2020 (11.5%). The main difference between both periods was the injury mechanism. |
| Publish Date |
2021-10-14 05:19 |
| Citation |
Mills S, Ibarzábal-Gil A, Martínez-Diez JM, Pallarés-Sanmartín J, Kalbakdij-Sánchez C, Rubio-Suárez JC, Losantos-García I, Rodríguez-Merchán EC. SARS-CoV-2 outbreak impact on a trauma unit. World J Orthop 2021; 12(10): 751-759 |
| URL |
https://www.wjgnet.com/2218-5836/full/v12/i10/751.htm |
| DOI |
https://dx.doi.org/10.5312/wjo.v12.i10.751 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
